tiprankstipranks
Trending News
More News >
Abacus Life (ABL)
NASDAQ:ABL
US Market
Advertisement

Abacus Life (ABL) AI Stock Analysis

Compare
126 Followers

Top Page

ABL

Abacus Life

(NASDAQ:ABL)

Select Model
Select Model
Select Model
Neutral 59 (OpenAI - 4o)
Rating:59Neutral
Price Target:
$7.00
▲(15.51% Upside)
Abacus Life's overall stock score is driven by strong earnings call performance, highlighting robust revenue growth and strategic financial management. However, financial performance is hindered by profitability and cash flow challenges, and valuation metrics are weak due to negative earnings.
Positive Factors
Revenue Growth
Strong revenue growth indicates increasing demand and effective market penetration, supporting long-term business expansion and stability.
Asset Management Performance
Robust asset management inflows enhance revenue streams and demonstrate effective portfolio management, strengthening the company's financial foundation.
Strategic Financial Management
Effective financial management and strategic asset sales improve profitability, showcasing operational efficiency and enhancing shareholder value.
Negative Factors
Profitability Challenges
Negative profitability impacts return on equity and may hinder reinvestment capabilities, posing a risk to long-term financial health.
Cash Flow Concerns
Persistent negative cash flow raises sustainability concerns, potentially limiting operational flexibility and growth opportunities.
Increased Operating Expenses
Rising operating expenses can pressure margins and reduce profitability, challenging the company's ability to maintain cost efficiency.

Abacus Life (ABL) vs. SPDR S&P 500 ETF (SPY)

Abacus Life Business Overview & Revenue Model

Company DescriptionAbacus Global Management, Inc. operates as an alternative asset manager and market maker in the United States. It operates in five segments: Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. The Active Management segment is involved in the buying, selling, and trading of policies; and the maintenance of policies until receipt of death benefits. Its Originations segment originates life insurance policy settlements between investors or buyers, and the sellers, who are often the original policy owners. The Asset Management segment provides asset management services to investors investing in alternative investment and equity portfolio funds based on fund investment agreements. Its Portfolio Servicing segment offers policy services to customers on a contract basis. The Technology Services segment provides real-time mortality verification, missing participant verification, and other services specific to the life insurance market services to customers on a contract basis. It sells its products through financial advisors or agents, direct-to-consumer, and traditional life settlements intermediaries. The company was formerly known as Abacus Life, Inc. and changed its name to Abacus Global Management, Inc. in February 2025. Abacus Global Management, Inc. was founded in 2004 and is headquartered in Orlando, Florida.
How the Company Makes MoneyAbacus Life makes money primarily through the acquisition and management of life insurance policies. The company purchases these policies at a discount from their face value and continues to pay the premiums. Upon the maturity of these policies, Abacus Life collects the death benefits, with the difference between the purchase price, premiums paid, and the death benefit amounting to profit. Key revenue streams include the proceeds from policy maturities and the management of a diversified portfolio of life insurance assets. Strategic partnerships with financial advisors, brokers, and insurance companies also play a significant role in sourcing policies and expanding the company's market reach.

Abacus Life Earnings Call Summary

Earnings Call Date:Aug 07, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Nov 17, 2025
Earnings Call Sentiment Positive
The earnings call reflected a strong performance by Abacus Global Management, highlighted by robust revenue and profit growth, successful asset management inflows, and strategic financial metrics. However, increased operating expenses and potential market uncertainties were noted as challenges. Overall, the positive aspects significantly outweighed the challenges mentioned.
Q2-2025 Updates
Positive Updates
Record Revenue and Profit Growth
Abacus Global Management almost doubled total revenue year-over-year to $56.2 million, increased adjusted net income to $21.9 million, and adjusted EBITDA to $31.5 million, driven by demand for less correlated investments.
Strong Asset Management Performance
New AUM inflows of approximately $142 million with total gross AUM increasing to nearly $3.3 billion. Asset Management business contributed $8.8 million in revenue.
Increased Outlook for 2025
Full year 2025 adjusted net income expected to be between $74 million and $80 million, implying growth of 59% to 72% year-over-year.
Successful Share Repurchase Program
A new $20 million share repurchase program was authorized, and 88% of outstanding warrants were tendered with a plan for the remaining 12% to be converted.
Strategic Operational Metrics
Increase in realized gain on policy sales with an average realized gain of 26.3% for Q2 2025, highlighting effective balance sheet management.
Negative Updates
Increased Operating Expenses
Total operating expenses increased to $27.4 million from $20.1 million in the prior year, primarily due to greater depreciation and amortization and increased marketing expenses.
Potential Market Uncertainty
Concerns over unpredictable economic conditions impacting future earnings, leading to cautious guidance despite strong first half performance.
Company Guidance
During the second quarter of 2025, Abacus Global Management reported a significant increase in total revenue, nearly doubling year-over-year to $56.2 million. The company also saw adjusted net income rise to $21.9 million and adjusted EBITDA grow to $31.5 million. Abacus achieved a notable asset inflow with new AUM of approximately $142 million and increased total gross AUM to nearly $3.3 billion. The company raised its full-year 2025 adjusted net income guidance to a range of $74 million to $80 million, reflecting an anticipated growth of 59% to 72% compared to 2024. The company's operations demonstrated strong balance sheet management with an annualized turnover ratio of 2.3x and a realized gain on sale average of 26.3% for Q2 2025. Abacus also announced a $20 million share repurchase program and highlighted a strong financial position with $74.8 million in cash and cash equivalents and $387.3 million in balance sheet policy assets as of June 30, 2025.

Abacus Life Financial Statement Overview

Summary
Abacus Life shows strong revenue growth but faces challenges with profitability and cash flow. The balance sheet is stable with low leverage, but negative net income impacts return on equity.
Income Statement
55
Neutral
Abacus Life shows a mixed income statement performance. The TTM data indicates a significant increase in total revenue compared to the previous annual period, resulting in a strong revenue growth rate. However, net profit margin is negative due to significant net losses, which raises concerns about profitability. The gross profit margin remains healthy, but the EBIT and EBITDA margins are inconsistent, reflecting volatility in operating performance.
Balance Sheet
65
Positive
The balance sheet of Abacus Life demonstrates a stable equity base with a reasonable equity ratio. The company has managed to maintain a low debt-to-equity ratio, indicating controlled leverage. However, the return on equity is impacted by negative net income, which is a concern for investors looking for profitable returns.
Cash Flow
45
Neutral
The cash flow analysis is concerning as Abacus Life reports negative operating cash flow in both TTM and previous annual periods, leading to negative free cash flow. This indicates cash management challenges. The operating cash flow to net income ratio is unfavorable due to persistent net losses, which raises sustainability risks.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue134.58M111.92M66.40M44.71M22.59M1.22M
Gross Profit118.82M100.55M59.91M38.83M8.39M710.01K
EBITDA22.78M12.72M23.33M34.81M349.41K-476.74K
Net Income-17.97M-23.96M9.52M31.68M997.41K1.44M
Balance Sheet
Total Assets856.51M874.16M331.83M59.09M5.29M3.74M
Cash, Cash Equivalents and Short-Term Investments43.76M131.94M27.84M30.05M2.60M1.85M
Total Debt361.04M385.91M141.74M28.33M1.05M148.97K
Total Liabilities420.93M450.87M167.76M30.95M29.23M160.70K
Stockholders Equity435.68M424.15M163.93M27.25M915.05K2.08M
Cash Flow
Free Cash Flow-273.44M-209.62M-64.71M10.61M1.12M904.09K
Operating Cash Flow-115.89M-208.81M-64.52M10.69M1.34M904.09K
Investing Cash Flow-8.69M-4.96M2.24M-3.70M-241.53K-345.00M
Financing Cash Flow259.73M320.12M57.82M22.96M-354.58K-329.10K

Abacus Life Technical Analysis

Technical Analysis Sentiment
Negative
Last Price6.06
Price Trends
50DMA
6.10
Negative
100DMA
6.43
Negative
200DMA
7.05
Negative
Market Momentum
MACD
-0.02
Positive
RSI
39.61
Neutral
STOCH
13.19
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ABL, the sentiment is Negative. The current price of 6.06 is below the 20-day moving average (MA) of 6.56, below the 50-day MA of 6.10, and below the 200-day MA of 7.05, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 39.61 is Neutral, neither overbought nor oversold. The STOCH value of 13.19 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ABL.

Abacus Life Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
3.82B14.6316.17%1.67%0.82%-29.29%
71
Outperform
3.10B5.867.82%59.27%
67
Neutral
3.69B20.323.52%2.61%465.03%
65
Neutral
289.92M26.017.09%-0.04%-49.18%
59
Neutral
$592.20M-0.34%69.59%38.07%
57
Neutral
67.31M33.57-4.28%0.61%6.98%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ABL
Abacus Life
6.06
-4.56
-42.94%
AAME
Atlantic American
3.30
1.76
114.29%
CIA
Citizens
5.77
2.34
68.22%
CNO
CNO Financial
39.42
5.48
16.15%
GNW
Genworth Financial
8.99
2.26
33.58%
BHF
Brighthouse Financial
54.21
10.50
24.02%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 19, 2025